As of July 2014, the market cap for ProShares UltraShort Nasdaq Biotechnology (BIS) is $70,800,000.00.
As of July 2014, the market cap for ProShares Ultra Nasdaq Biotechnology (BIB) is $355,914,000.00.
As of July 2014, the market cap for iShares NASDAQ Biotechnology Index Fund (IBB) is $5,083,455,000.00.
During an economic downturn, the best bear market ETF to invest in is one that aims to provide inverse or short exposure to the stock market, such as the ProShares Short SP 500 ETF (SH) or the ProShares UltraShort SP 500 ETF (SDS). These ETFs are designed to increase in value when the stock market declines.
As of July 2014, the market cap for ProShares UltraPro QQQ (TQQQ) is $634,557,000.00.
As of July 2014, the market cap for ProShares UltraPro Short QQQ (SQQQ) is $351,897,000.00.
The easiest way to short the overall stock market is with ETF's. ProShares Short S&P 500, ticker SH, is not leveraged, ie. if the S&P declines 1%, the ETF increases 1%. Or you can invest in ProShares UltraShort S&P 500, ticker SDS, which is leveraged 2.5 to 1; thus if the S&P declines 1%, the ETF increases 2.5%. Good luck.
The NASDAQ is a dealer market. Buyers of stock do not buy and sell from one another directly, but through NASDAQ, a market maker.
As of July 2014, the market cap for Puma Biotechnology Inc (PBYI) is $6,412,686,021.48.
As of July 2014, the market cap for Prana Biotechnology Ltd (PRAN) is $97,873,056.15.
The ticker symbol for Nasdaq Stock Market is NDAQ and, not surprisingly, it trades on the Nasdaq.
The NASDAQ Composite is a stock market index of the common stocks and similar securities listed on the NASDAQ stock market, meaning that it has over 3000 components.
Yes.